Skip to main content

Table 1 Patient characteristics

From: A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium

 

No.

%

No. included

41

100

Median age (years)

64.5(45–75)

 

Male/female

31

75.6

 

10

24.4

ECOG-PS

  

   0

9

21.9

   1

27

65.9

   2

5

12.2

Primary tumour

  

   bladder

30

73.2

   ureter

5

12.2

   renal pelvis

6

14.6

Creatinine clearance (ml/min)

  

   ≥ 30 and < 60

8

19.5

   ≥ 60

33

80.5

Disease status

  

   Locally advanced disease

17

41.5

   Metastases disease

24

58.5

Lymph nodes

18

43.9

Bones

5

12.2

Lung

6

14.6

Liver

5

12.2

Multiple site involvement

6

25

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us